β -Adrenergic receptor (β-AR) activation, which is chronic in heart failure (HF), can provoke cardiac arrhythmias as a result of abnormal diastolic Ca 2+ release from the sarcoplasmic reticulum (SR) via phosphorylation of the ryanodine receptor (RyR2). [1] [2] [3] This also contributes to reduced cardiac contractility caused by a reduced SR Ca 2+ load and systolic SR Ca 2+ transient. [4] [5] [6] [7] Early studies of enhanced SR Ca 2+ leak in HF or with β-AR activation focused on protein kinase A (PKA), a classic cAMP target. 1 However, β-AR activation can also induce PKA-independent diastolic SR Ca 2+ leak mediated by Ca 2+ /calmodulin-dependent protein kinase II (CaMKII). [8] [9] [10] [11] [12] Indeed, Epac (exchange protein directly activated by cAMP), a cAMP target, has been shown to increase diastolic SR Ca 2+ leak via CaMKII. 12 Two Epac isoforms have been identified. Epac1 (with 1 cAMP-binding domain) seems ubiquitously expressed, whereas Epac2 (with 2 cAMP-binding sites) seems more prominent in brain, pituitary, and adrenal gland. [13] [14] [15] February 26, 2013
First, most prior work implicating Epac has relied on the pharmacological selective agonist 8-CPT, which could have off-target effects. 26 Second, it is unknown which Epac isoform mediates RyR and arrhythmogenic effects of Epac activation. Third, it is unknown whether these effects are mediated by type 1 or type 2 β-AR (β 1 -AR or β 2 -AR). Fourth, it has been proposed that Epac-mediated effects might require higher levels of β-AR activation than for PKA activation. Fifth, it is unknown whether and to what extent Epac contributes to β-AR-induced arrhythmias. Sixth, it is not known if the Epacdependent effects on SR Ca 2+ release require the major cardiac CaMKIIδ isoform or if other isoforms suffice. Finally, it is also unclear whether the SR Ca 2+ release effects of Epac require the putative RYR CaMKII site S2814. Here, we generated Epac-knockout (KO) mice and use other genetically altered mice to unequivocally address all of those points.
We demonstrate that Epac-KO did not alter cardiac function, early pressure overload-induced hypertrophy, or basal myocyte Ca 2+ handling. Epac-dependent arrhythmogenic effects were prevented by ablation of Epac2, β 1 -AR, CaMKIIδ, and RyR2-S2814 phosphorylation. Epac2 mediates β 1 -ARinduced cardiac arrhythmias via CaMKIIδ and RyR2-S2814 phosphorylation.
Methods
An expanded Method section is provided in the online-only Data Supplement.
Epac-KO Mouse Lines
Epac1-and Epac2-KO mice were developed via similar strategies (see the online-only Data Supplement). The Epac1-KO mice were also used in a parallel initial project. 27 Epac1/Epac2 double-KO mice (DKO) were obtained by breeding heterozygous Epac1-KO and Epac2-KO mice to generate double-null mice. Littermate Epac2-null mice were used as controls. All procedures were performed in accordance with NIH Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee of the University of California San Diego.
CaMKIIδ-KO, RyR2-S2814A, and -S2814D Mice
Homozygous CaMKIIδ-KO mice were generated from heterozygous CaMKIIδ mice as previously described. 28 RyR2-S2814A and RyR2-S2824D knock-in mice were previously described 29 and inhibit or mimic CaMKII phosphorylation, respectively, at this site on RyR2.
Myocyte Isolation
Cardiac ventricular myocytes were isolated with the retrograde Langendorff perfusion technique with type 2 collagenase (Worthington) perfusion. Cells were kept in 1 mmol/L [Ca] (20°C-22°C) before the experiments were started. Epac-KO cardiomyocytes were isolated from 3-and 10-month-old mice. There were no apparent differences between age groups. All procedures were approved by the University of California Davis Institutional Animal Care and Use Committee.
Echocardiography
Anesthetized mice were analyzed by echocardiography and hemodynamics in 8-month-old wild-type (WT) and Epac1-KO mice, 18-month-old WT and Epac2-KO mice, and 18-month-old control and Epac-DKO mice. Hemodynamic analysis was performed in 3-month-old Epac1-KO and WT mice and 5-month-old Epac-DKO and control mice. Transverse aortic constriction was performed in 3-month-old male Epac1 or Epac2, and age-matched WT control mice went through either sham operation (n=3) or transverse aortic constriction surgery (n=6-9).
In Vivo Electrophysiology
Programmed intracardiac stimulation was performed in age-matched control and homozygous Epac2-KO mice as previously described. 30 The incidence of reproducible sustained ventricular tachycardia (VT; episode >10 consecutive beats of VT) was determined with or without isoproterenol (ISO; 0.5 mg/kg IP).
Line Scan Confocal Microscopy
Ca 2+ transient, SR Ca 2+ leak, and SR Ca 2+ load were assessed in freshly isolated cells loaded with 5 μmol/L Fluo-3 AM or Fluo-4 AM (Molecular Probes) 12 using confocal microscopy (BioRad, Radiance 2100, ×40 oil immersion objective). Excitation was at 488 nm (Ar Laser) and emission at >505 nm. Adenoviral fluorescence resonance energy transfer (FRET) based cAMP indicator 31 was provided by Dr Y.K. Xiang (University of California Davis). Image analysis was performed with ImageJ software and homemade routines in Interactive Data Language (ITT).
Quantitative Polymerase Chain Reaction
Quantitative polymerase chain reaction was done with GAPDH (QT01658692, Qiagen) as control: Epac1-1: forward, 5ʹ-CTCTGT CTCTGCCCTGTTCC-3ʹ; reverse, 5ʹ-CGCAAAGAAAGAGTTG AGG-3ʹ; Epac1-2: forward, 5′-TGTTGGTGAAGGTCAATTCTG-3′; reverse, 5′-CCACACCACGGGCATC-3′; Epac2-1: forward, 5ʹ-GG CGTACCAGATGACAACCT-3ʹ; reverse, 5ʹ-CCTCCTCAGGAACA AATCCA-3ʹ; and Epac2-2: forward, 5′-TGTTAAAGTGTCTGAGAC CAGCA-3ʹ; reverse, 5′-AAAGGCTGTCCCAATTCCCAG-3′.
Antibodies
Epac1 antibody was a gift from Dr Xiaodong Cheng (University of Texas Medical Branch). Epac2 and GAPDH antibodies were purchased from Santa Cruz.
Statistical Analysis
Data are expressed as mean±SEM. For multiple-group comparisons, a 1-way ANOVA test was followed by a Bonferroni post hoc test. A repeated measures 2-way ANOVA test was followed by a Bonferroni post hoc test to examine the effect of drug application (before versus after) between multiple groups. Statistical discrimination between 2 populations (with or without treatment) was evaluated by the Student t test for independent samples and paired t tests for matched samples. Differences were considered significant at P<0.05.
Results

Generation of Epac1-and Epac2-KO Mouse Lines
Epac1-and Epac2-KO mice were generated with the Cre-loxP system by floxing exons 3 to 5 and 7, respectively ( Figure IA Cardiomyocytes may express Epac1 and Epac2 mRNA at different levels. 23 Quantitative polymerase chain reaction showed higher Epac2 mRNA than Epac1 mRNA in both heart homogenates and isolated cardiomyocytes ( Figure IIA in the online-only Data Supplement). Epac1 protein level was not altered in Epac2-KO compared with WT control hearts (not shown), nor was Epac2 mRNA altered in Epac1-KO mice ( Figure IIB in the online-only Data Supplement), although we could not assess this at the protein level.
Epac Is Not Critical to Baseline Cardiac Function
In vivo baseline cardiac function was normal in all 3 KOs in terms of left ventricular (LV) posterior wall thickness, LV internal dimension, and fractional shortening compared with WT for up to 18 months of age ( Figure 1 and Table I in the online-only Data Supplement). Moreover, heart rates, LV pressure, +dP/dt max , −dP/dt max , and response to dobutamine perfusion were unchanged ( Table I in the online-only Data Supplement). None of the deletions appreciably affected basal cardiac function or ratio of heart weight to body weight ( Figure 1D ), nor were there any significant differences in transverse aortic constriction (3-4 weeks)-induced hypertrophy, cardiac dysfunction ( Figure 1E and 1F and Figure  III in the online-only Data Supplement), or expression levels of SERCA or Na + /Ca 2+ exchange (in preliminary Western analysis) in either Epac-KO mouse. The lack of differential phenotype discouraged further study of these transverse aortic constriction mice (TAC).
At the myocyte level, basal Ca 2+ transient amplitude and time constant of intracellular Ca 2+ concentration ([Ca 2+ ] i ) decline (τ twitch ) indicative of SR Ca 2+ -ATPase function ( Figure  2A and 2B) and SR Ca 2+ content and Na + /Ca 2+ exchange function (Figure 2A -2D) were not significantly different between groups. Diastolic Ca 2+ spark frequency (CaSpF; a measure of SR leak) was unaltered among the groups, particularly when normalized to SR Ca 2+ load (to account for the intrinsic effect of SR Ca 2+ load on CaSpF; Figure 2D and 2E). So, Epac ablation does not appreciably alter baseline Ca 2+ handling. This is consistent with the idea that basal [cAMP] and Epac activation are low in adult ventricular myocytes in the absence of agonists or phosphodiesterase inhibition. It also creates a uniform baseline with which to examine the role of Epac during β-AR activation.
Epac2, Not Epac1, Is Responsible for PKA-Independent SR Ca 2+ Leak
To test which Epac isoform mediates the previously reported 8-CPT-induced increase in SR Ca 2+ release, 12 we measured CaSpF in isolated ventricular myocytes. Figure 3A shows that when 10 µmol/L 8-CPT was applied to individual WT myocytes, CaSpF was enhanced, as previously described. 12 The same was observed in Epac1-KO (especially when normalized to SR Ca 2+ load; Figure 3C ). In contrast, the 8-CPT-induced increase in CaSpF was totally abolished in Epac2-KO or DKO mice ( Figure 3A and 3C). 
Epac2 Contributes to β-AR-Induced Cardiac Arrhythmias
Because Epac2 can enhance diastolic SR Ca 2+ release, we tested whether Epac2 might contribute to β-AR-induced arrhythmias. This was assessed in vivo as the ability of programmed electric stimulation to induce sustained VT before or after ISO injection (0.5 mg/kg IP). This protocol was intentionally aggressive so that all WT exhibited sustained VT (P<0.001 versus control). This allowed the detection of reduced susceptibility and sustained VT duration in Epac2-KO compared with WT (50%; P<0.05 versus WT; Figure 4A and C). Furthermore, Epac2-KO exhibited reduced tendency to VT compared with WT after a burst pacing protocol ( Figure  IV in the online-only Data Supplement). WT and Epac2-KO mice did not exhibit differences in heart rate, ECG parameters, or refractory periods at baseline or in response to ISO (Tables  II and III in the online-only Data Supplement). There was also no difference in ventricular effective refractory period between WT and Epac2-KO mice (with or without ISO; Table  IV in the online-only Data Supplement), suggesting that the arrhythmia is unlikely to be due to altered repolarization but may indeed reflect reduced triggered activity in Epac2-KO related to less RyR sensitization.
To complement those in vivo arrhythmia measurements, we assessed ISO-induced increases in CaSpF in Epac2-KO cardiomyocytes, reasoning that SR Ca 2+ release events may be a key underlying mechanism for these triggered arrhythmias ( Figure 4D ). ISO increased CaSpF in WT, but this effect was dramatically blunted in Epac2-KO. The residual CaSpF enhancement in Epac2-KO mice was abolished by PKA inhibition with H89 (a potent inhibitor of PKA). ISO-induced Ca 2+ waves also tended to be less frequent in Epac2-KO compared with WT myocytes (79±24% versus 132±48% increase; P=NS). In Epac2-KO mice, the inhibition of PKA by H89 fully reversed the effects of ISO on Ca 2+ transient amplitude ( Figure V in the online-only Data Supplement), and correction for SR Ca 2+ load ( Figure 4E ) did not alter this interpretation. We conclude that Epac2 activation (in parallel with PKA) contributes significantly to β-AR-induced triggered arrhythmias and the SR Ca 2+ release events that may underlie them.
Epac Is Activated by Moderate Levels of β-AR Stimulation
β-AR stimulation activates PKA and Epac and alters SR Ca 2+ leak by phosphorylation of phospholamban (via elevated SR Ca 2+ load) 32 or of RyR2 (which is controversial). 1, 5, [32] [33] [34] To better understand the physiological significance of Epac signaling, we tested direct β-AR stimulation with or without PKA inhibition. First, we assessed the isoproterenol concentration ([ISO]) needed for maximal effects on inotropy, lusitropy, and Ca 2+ sparks ( Figure 5A and 5B). ISO induced a concentrationdependent increase in Ca 2+ transient amplitude, CaSpF, and τ twitch (indicative of phospholamban phosphorylation effects). The lusitropic effect was maximal at ≈100 nmol/L ISO, whereas Ca 2+ transient amplitude and CaSpF were maximal at 100 to 300 nmol/L ISO. Thus, we focused on the 30 to 300 nmol/L range of [ISO] with PKA blocked by pretreatment with 2 µmol/L H89. H89 can influence [cAMP] achieved by ISO application because of PKA effects on phosphodiesterases, which was tested in control experiments using a FRET-based cAMP sensor 35 H89 pretreatment blocked the ISO-induced increase of Ca 2+ transient amplitude, SR Ca 2+ load, and τ twitch ( Figure VII in the online-only Data Supplement), consistent with potent PKA inhibition. In contrast, ISO still greatly increased CaSpF with PKA blocked at all [ISO] ( Figure 5C ) and decreased Ca 2+ transient amplitude ( Figure 5D ). Both of these effects are similar to those observed on Epac activation by 8-CPT ( Figure  5C and 5D ). This implies that most of the PKA-independent CaSpF enhancement is mediated by Epac. The ISO-mediated decrease in Ca 2+ transient amplitude when PKA is blocked is consistent with the idea that PKA is required for the β-ARdependent positive inotropic effect but that other β-AR-mediated effects negatively influence Ca 2+ transients (eg, SR Ca 2+ unloading via Epac). Notably, 30 nmol/L ISO+H89 was sufficient to fully induce the PKA-independent enhancement of CaSpF, comparable to that induced by 8-CPT. This suggests that physiologically relevant β-AR activation may activate the Epac2 pathway in parallel to PKA and at similar [cAMP] and that both pathways contribute to arrhythmogenesis.
Epac-Induced SR Ca 2+ Leak Is Activated by β 1 -AR
Next, we sought to determine whether β 1 -AR or β 2 -AR is responsible for mediating the Epac-dependent activation of Ca 2+ sparks and arrhythmias. 11, 12, 17 Figure 6 illustrates rat myocytes for comparison with mouse data obtained in other figures and previous reports. Both 8-CPT and ISO increased CaSpF ( Figure 6A ) and reduced steady-state SR Ca 2+ load ( Figure 6C ), as seen in mouse experiments (Figure 3 ). The lower SR Ca 2+ load in rat myocytes treated with 8-CPT may be secondary to the increase in CaSpF. This would actually feed back to limit the rise in CaSpF (resulting from lower luminal SR Ca 2+ ). As in mouse myocytes, in studies with rat myocytes, ISO+H89 produces effects similar to those of 8CPT alone ( Figure 6A-6C ). Thus, ISO+H89 is a good treatment to assess β-AR-induced Epac effects independently of PKA.
To determine the β-AR subtype involved, we treated cells with specific β 1 -AR and β 2 -AR inhibitors (along with H89) before ISO exposure. β 1 -AR blockade (CGP-20712A) was able to fully prevent the ISO-induced increase in CaSpF, whereas the response after β 2 -AR blockade (ICI-118.551) was not different from ISO+H89 ( Figure 6A ). Consistent with this result, CGP-20712A also restored Ca 2+ transient amplitude (99.4±6.2% of control) compared with 8-CPT or ISO+H89 (166±23% and 165±22%; Figure 6B ). The 8-CPT-or ISO+H89-dependent rise in SR Ca 2+ leak results in a decrease in SR Ca 2+ load in both cases ( Figure 6B ), which is partially prevented by β 1 -AR block.
Epac Mediates RyR2-S2814 Phosphorylation via CaMKIIδ
Our previous work suggested that the Epac-induced CaSpF enhancement involved CaMKII activation and RyR2 phosphorylation. 12 However the phosphorylation site and CaMKII isoform required are unknown. RyR2-S2814 has been suggested as an important CaMKII phosphorylation target. 30, 36 To test its requirement for Epac-dependent effects, we used RyR2-S2814 knock-in mice. In those mice, S2814 was rendered either nonphosphorylatable (RyR2-S2814A) 29 or phosphomimetic (RyR2-S2814D). 30 In WT mice, CaMKII inhibition (1 μmol/L KN93) blocked the 8-CPT-induced increase in CaSpF and the reduction in SR Ca 2+ load and Ca transient ( Figure 7A-7D ). The same effects were observed in both knock-in mice, suggesting that this CaMKII target (and presumably the leak induced) is sufficient to depress twitch Ca 2+ transients. These results prove that phosphorylation of this CaMKII target site is essential for Epac-dependent activation of SR Ca 2+ leak.
Notably, the S2814A mice behaved most like WT+KN-93, whereas the S2814D mice exhibited much higher basal CaSpF and lower SR Ca 2+ load (as recently reported) 30 but were not significantly modulated by 8-CPT. This is consistent with S2814D being phosphomimetic for CaMKII effects at that site. 37 Moreover, the unaltered baseline Ca 2+ transient amplitude, despite reduced SR Ca 2+ load in S2814D mice, is consistent with the CaMKII-dependent enhancement of fractional SR Ca 2+ release at a constant SR Ca 2+ load and Ca 2+ current trigger 38 and hence allows relatively normal Ca 2+ transients. CaMKIIδ is the dominant CaMKII isoform in cardiomyocytes (70% to 90%), but other isoforms (eg, CaMKIIγ) could phosphorylate certain targets and contribute to the inhibitory effects of KN93. 28 To test whether the Epac2dependent effect on Ca 2+ sparks is mediated via CaMKIIδ specifically, we assessed Ca 2+ transients and sparks in WT compared with CaMKIIδ-KO mice ( Figure 7E and 7F) . 
Discussion
The relatively specific Epac activator 8-CPT has been shown to induce diastolic SR Ca leak and arrhythmias, and in human HF, Epac expression is increased. Thus, understanding how Epac-dependent arrhythmogenic signaling works is important. 8-CPT could have off-target effects, 26 negligible with respect to Ca 2+ handling because 10 µmol/L 8-CPT had no acute effect on Ca 2+ transients or Ca sparks in Epac2-KO and -DKO myocytes. We conclude that myocyte Epac2 is essential for the 8-CPT-induced RyR activation and that Epac1 cannot be substituted. The Epac2-mediated effects on RyR can be induced via β 1 -AR activation (not by β 2 -AR) and contribute significantly (along with PKA) to β-AR activation-dependent arrhythmogenesis in hearts and myocytes. The fact that the ISO-induced Ca spark enhancement was partially prevented in Epac2-KO mice and further suppressed by PKA inhibition (Figure 4D) suggests that Epac2 and PKA are the main pathways here. Other modulators like nitrosylation or oxidation do not seem critical (but could become relevant under some conditions). CaMKIIδ is required for these Epac2-mediated effects, and other CaMKII isoforms (which constitute ≈20% of myocyte CaMKII activity) 35 cannot be substituted. One specific site on RyR2 (S2814) also seems essential for Epac2-dependent RyR effects despite the presence of other phosphorylation sites on RyR2. 39 This provides novel insight into how Epac works in parallel with the classic cAMP/PKA pathway in cardiomyocytes with respect to Ca 2+ handling and arrhythmias in heart.
Epac2, a Key Protein for β-AR-Mediated SR Ca Leak and Arrhythmia
At baseline, Epac has little impact on cardiac function and Ca 2+ signaling because none of the Epac-KO mice exhibited changes in baseline ratio of heart weight to body weight, cardiac function, or myocyte Ca 2+ handling (including diastolic SR Ca 2+ leak, SR Ca 2+ load, or global SR Ca 2+ release). However, Epac is called into play during acute physiological β-AR activation, and this could be exacerbated in pathological contexts such as chronic β-AR stimulation during HF. Indeed, Epac2-KO mice were less susceptible to triggered arrhythmias on β-AR activation, and their myocytes produced less arrhythmogenic Ca 2+ sparks (Figure 4) . In contrast, our data here showed that neither Epac-KO significantly altered transverse aortic constriction-induced hypertrophy or the associated cardiac function changes ( Figure 1E and 1F and Figure  IIIA -IIID in the online-only Data Supplement). These data are consistent with the idea that Epac activation plays a more significant role in β-AR-induced myocyte Ca 2+ mishandling and arrhythmias than in the initial stages of hypertrophy. Indeed, Epac activation by 8-CPT in whole hearts increased diastolic SR Ca 2+ leak and ventricular arrhythmogenesis. 17 We cannot rule out that Epac might be involved in signaling related to HF, 22, 40 and to the extent that this CaMKII/RyR2 pathway might be critical in the transition from compensated hypertrophy to HF as seen in CaMKIIδ-KO mice, 28 functional upregulation of this Epac pathway during cardiomyopathy 1, 23 may contribute to this transition to HF.
We discovered that only Epac2 mediates enhanced SR Ca 2+ leak and thus might have different signaling pathways than Epac1 in heart. We found greater Epac2 than Epac1 mRNA expression in cardiomyocytes, and whereas Epac1 mRNA is clearly expressed in heart, 14, 15, 23 the Epac1/Epac2 mRNA ratio decreases in adulthood compared with neonates, 23 making it plausible that Epac2 may have increasing functional effects with age. We anticipate that Epac1 mediates different functions in cardiomyocytes. Indeed, Epac1 is part of a nuclear musclespecific A-kinase anchoring protein complex, reinforcing the idea of its role in nuclear signaling. 41
Role of Epac Versus PKA During β-AR-Mediated SR Ca 2+ Leak
Acute Epac activation with 8-CPT has been reported to either increase 11, 16 or decrease (present study) 12, 19 Ca 2+ transient amplitude, but this may only be an apparent discrepancy related to experimental protocols. We and others 12, 19 focused on 8-CPT effects during steady state when Ca 2+ transients were decreased. In contrast, larger initial Ca 2+ transients during the first 20 seconds are also seen, 11, 16 consistent with RyR activation (which we describe). This is similar to the effect of low concentrations of the RyR sensitizer caffeine 42 in which initial Ca 2+ transients are larger (sensitized release) but they drive greater Ca 2+ efflux and progressively lower SR Ca 2+ load. If diastolic SR Ca 2+ leak is also enhanced, this can result in lower steady-state Ca 2+ transients than control, as observed with CaMKII activation. 43, 44 All agree that Epac activation causes CaMKII-dependent RyR sensitization. Epac activation increases CaMKII-dependent RyR2 sensitivity to Ca 2+ , which paralleled the alteration described during HF. Indeed, cardiac contraction is reduced in HF, in part because reduced SR Ca 2+ content attributed to SR Ca 2+ leak increases via CaMKII despite a relative sensitization of the RyR. 6, 8, 21, 45, 46 Thus, Epac may, along with PKA, be an important downstream effector of β-AR/cAMP-mediated effects in HF.
It is thought that Epac activation requires higher levels of cAMP compared with activation of PKA, [47] [48] which would imply that low levels of β-AR activation might preferentially activate PKA and higher levels would recruit both PKA and Epac. Our data indicate that 30 nmol/L ISO was sufficient to induce maximal Epac-dependent RyR2 effects, a lower [ISO] than required for maximal PKA-dependent effects ( Figure 5 ). Thus, during β-AR stimulation in myocytes, Epac activation likely overlaps with PKA. Indeed, both ISOinduced arrhythmias and SR Ca 2+ leak effects were strongly attenuated in Epac2-KO mice, reinforcing the idea that Epac and PKA are coactivated in β-AR-induced SR Ca 2+ leak and arrhythmias. Global β-AR activation (PKA+Epac) enhances SR Ca 2+ leak, Ca 2+ transients, and SR Ca 2+ load. In contrast, under Epac activation alone, Ca 2+ transients and SR Ca 2+ load decrease because of higher SR Ca 2+ leak. The enhanced SR Ca 2+ load and Ca 2+ transients with global β-AR activation can be explained by strong PKA effects on Ca 2+ current and phospholamban, which increase SR Ca 2+ -ATPase activity and SR Ca 2+ load. Epac-dependent effects may limit the rise of SR Ca 2+ load driven by PKA-dependent effects. Consequently, we expected that β-AR-induced inotropy might be slightly enhanced in Epac-KO mice. This effect was not detected ( Table I in the online-only Data Supplement), possibly because the very strong positive inotropic effects of PKA overcome the modest Epac-mediated negative inotropy. Indeed, the Epac-induced RyR sensitization coupled with increased SR Ca 2+ load and Ca 2+ current could ablate the moderate negative inotropic effect of Epac.
Epac2 Signaling Pathway in β-AR-Mediated SR Ca 2+ Leak
In cardiomyocytes, β 1 -AR and β 2 -AR coexist. Here, only β 1 -AR inhibition blocked Epac-mediated Ca 2+ signaling alterations. This agrees with previous work in which β 1 -AR favored the formation of a Epac/CaMKII/β-arrestin complex 50 and where β 1 -AR deletion attenuated CaMKII activation. 51 Because Epac also activates CaMKII, 11,12,17 these findings reinforce Epac and CaMKII signaling downstream of β 1 -ARs (at least at the RyR) and the link between CaM-KII-dependent SR Ca 2+ leak and arrhythmias. 17, 24 The genetic block of RyR S2814 phosphorylation, CaMKIIδ-KO, and KN93 fully abolished 8-CPT-induced SR Ca 2+ leak in WT (Figure 7 ). These data extend previous studies 11, 12, 17 suggesting that Epac-induced RyR2-S2814 phosphorylation depends on CaMKIIδ and not on other CaMKII isoforms. However, in RyR2-S2814D mice, we observed a larger SR Ca 2+ leak at baseline compared with 8-CPT, suggesting that Epac may not achieve the maximum RyR2 activation seen in phosphomimetic RyR2-S2814D mice.
Conclusions
Our work indicates that β 1 -AR activates Epac2-dependent SR Ca 2+ leak and arrhythmia via CaMKIIδ-dependent phosphorylation of RyR2-S2814. These findings give new insights into Epac physiology and pathology. Indeed, Epac seems nonessential for baseline cardiac function and does not significantly attenuate the acute inotropic response to potent β-AR activation or the early hypertrophic response to pressure overload. However, we demonstrate a specific role for the Epac2 isoform in mediating PKA-independent SR Ca 2+ leak via β 1 -AR, causing RyR-S2814 phosphorylation by CaMKIIδ and SR Ca 2+ leak. Further investigations are needed to understand why both Epac and PKA are activated by β 1 -AR stimulation and the role of Epac1 (nuclear signaling versus RyR function or transition to HF).
